Basal cell epithelioma (BCE) is the most common cutaneous malignancy. Primary BCE (ie, previously untreated) can be satisfactorily treated by a variety of methods, including curettage with electrodesiccation, scalpel excision, cryosurgery, and radiotherapy. Cure rates approach 98%. Recurrent BCE is much more difficult to treat and deserves particularly aggressive therapy, such as chemosurgery.